MarketMindUS Markets Closed
AI-assisted · Not financial adviceNot adviceAI-assisted · Not financial advice.
Retail sentiment is bullish as healthcare stocks gain traction. News scrutiny over Q2 results suggests a need for careful evaluation of performance.
Scrutiny over Q2 results and product performance
Target: $260 avg
21 Buy · 16 Hold · 3 Sell
Based on curated news sources (not retail comments)
Over the last 7 days: Johnson & Johnson has received positive regulatory feedback and saw a share surge, but faces scrutiny over its Q2 results due to competitive pressures.
Options positioning: Bearish — More betting on downside (1.7× more put than call volume today). Unusual bets on $252 downside — 1.07× normal activity. earnings 2026-07-15. analysts: 21 buy vs 3 sell.